Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Registry Study Focusing on the Real World Use, Effectiveness and Safety of Initial Basal Insulin Regimen in Type 2 Diabetic Patients Uncontrolled by Oral Antidiabetic Drugs in China

NCT01859598 is registered in ClinicalTrials.gov with The George Institute for Global Health, China as lead sponsor.

NCT NCT01859598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01859598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Registry Study Focusing on the Real World Use, Effectiveness and Safety of Initial Basal Insulin Regimen in Type 2 Diabetic Patients Uncontrolled by Oral Antidiabetic Drugs in China
Lead sponsor
The George Institute for Global Health, China
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
June 30, 2014
Enrollment
19,894 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes